Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data

@article{Staa2011GlucoseloweringAA,
  title={Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data},
  author={Tjeerd Van Staa and Deven J. Patel and Anne Marie Gallagher and Marieke L. De Bruin},
  journal={Diabetologia},
  year={2011},
  volume={55},
  pages={654-665}
}
IntroductionRecent studies suggesting an increased cancer risk with glucose-lowering agents have received widespread publicity. The objectives of this study were to evaluate the comparability in underlying cancer risk and patterns of cancer risk over time with different glucose-lowering agents.MethodsThe General Practice Research Database (GPRD) was used to identify cohorts of new users. Cancer outcomes were obtained from the GPRD, Hospital Episode Statistics and cancer registries. Relative… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 74 CITATIONS, ESTIMATED 62% COVERAGE

Insulin Therapy and Cancer in Type 2 Diabetes

  • ISRN endocrinology
  • 2012
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 5 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2011

Similar Papers

Loading similar papers…